Compensating RBM17 in knockdown MSI2 and MSI2 in knockdown RBM17 resulted in significantly larger tumors compared to control, indicating that RBM17 partially restored the inhibition of tumors in knockdown MSI2 and MSI2 partially restored the inhibition of tumors in knockdown RBM17 on tumor suppression. This evidence concerns the gene MSI2 and neoplasm.